Kevin R. Sayer, President CEO and Chairman at DEXCOM INC (DXCM), sold 162,014 shares at $134.41 ($21.6M) on 2024-03-12, disclosed to the SEC on 2024-03-14.
Scheduled sale ($21.6M) by President CEO and Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $131.47 | 12,470 | $1.6M | 7.6% |
| 2 | $131.47 | 12,470 | $1.6M | 7.6% |
| 3 | $132.43 | 14,993 | $2.0M | 9.2% |
| 4 | $132.43 | 14,993 | $2.0M | 9.2% |
| 5 | $133.55 | 20,930 | $2.8M | 12.9% |
| 6 | $133.55 | 20,930 |
| $2.8M |
| 12.9% |
| 7 | $134.07 | 2,939 | $394K | 1.8% |
| 8 | $134.07 | 2,939 | $394K | 1.8% |
| 9 | $134.41 | 29,675 | $4.0M | 18.5% |
| 10 | $134.41 | 29,675 | $4.0M | 18.5% |
| Total | $133.36 avg | 162,014 | $21.6M | 100% |
| Filing → |
| DXCM | SELL | 2026-07-07 | $1.9M | — | Filing → |
| DXCM | SELL | 2026-05-26 | $1.9M | — | Filing → |
| DXCM | SELL | 2025-03-14 | $4.6M | — | Filing → |